Bastide Le Confort Medical SA

40
Sell
  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: FR0000035370
EUR
22.90
-0.15 (-0.65%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationCash Flow
Bastide Le Confort Medical SA Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Jun'25
Jun'24
Jun'23
Jun'22
Jun'21
Jun'20
No of Months
12
12
12
12
12
12
Profit Before Tax
10.00
13.00
22.00
21.00
20.00
20.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
5.00
-10.00
10.00
-28.00
-1.00
-22.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
71.00
47.00
90.00
46.00
66.00
39.00
Cash Flow from Investing Activities
-56.00
-37.00
-76.00
-104.00
-73.00
-50.00
Cash Flow from Financing Activities
-4.00
-30.00
7.00
39.00
9.00
25.00
Net Cash Inflow / Outflow
10.00
-20.00
21.00
-18.00
2.00
14.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
0.00
0.00
0.00
0.00
0.00
0.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in EUR Million
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Bastide Le Confort Medical SA
Markets Mojo
Figures in Million
consolidated Cash Flow Results
Markets Mojo
Markets Mojo
Change(EUR)
Change(%)
Profit Before Tax
10.512
11.888
-1.00
-11.57%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
5.155
98.779
-93.00
-94.78%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
71.872
796.46
-725.00
-90.98%
Cash Flow from Investing Activities
-56.439
137.55
-193.00
-141.03%
Cash Flow from Financing Activities
-4.335
-670.898
666.00
99.35%
Net Cash Inflow / Outflow
10.947
263.112
-253.00
-95.84%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
-0.151
0
0.00
0.00%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Jun'25
stock-summary

YoY Growth in year ended Jun 2025 is 50.54% vs -47.12% in Jun 2024

Jun'25
Jun'24
Change(%)
Cash Flow from Operating Activities
71.87
47.74
50.54%